Proceedings of the GRAPPA 2022 Executive Retreat

Overview

Journal J Rheumatol

Specialty Rheumatology

Date 2023 Aug 1

PMID 37527861

Authors

Beverly Cheok Kuan Ng

Deepak Jadon

Adewale Adebajo

Gizem Ayan

Kristina Callis Duffin

Vinod Chandran

Laura C Coates

Maria Antonietta DAgostino

Kurt De Vlam

Atul Deodhar

Lihi Eder

Amit Garg

Dafna D Gladman

Niti Goel

Alice B Gottlieb

M Elaine Husni

Arnon Katz

Arthur Kavanaugh

Ennio Lubrano

Philip J Mease

Joseph F Merola

Peter Nash

Alexis Ogdie

Stephen R Pennington

Lourdes M Perez-Chada

Fabian Proft

Cheryl F Rosen

Laura Savage

Claudia Goldenstein-Schainberg

Stefan Siebert

Enrique R Soriano

Ingrid Steinkoenig

William Tillett

April W Armstrong

Oliver FitzGerald

Affiliations

Soon will be listed here.

Abstract

The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) leadership congregated for a strategic planning meeting before the 2022 GRAPPA annual meeting in New York, USA. Meeting aims were to review GRAPPA's performance in relation to its 2016 goals and identify successes and areas for further improvement, identify key GRAPPA priorities and activities for the next 5 years, and explore committee structures to best support these aims.

Citing Articles

Ixekizumab for Active Radiographic Axial Spondyloarthritis in Chinese Patients: 16- and 52-Week Results from a Phase III, Randomized, Double-Blind, Placebo-Controlled Study.

Xue Y, Hu J, Liu D, Li J, Wu H, Tan C BioDrugs. 2023; 38(1):145-156.

PMID: 37737952 DOI: 10.1007/s40259-023-00625-2.